| TX | HB3058 | Pass | Relating to the provision of certain medical treatment to a pregnant woman by a physician or health care provider.
[Detail][Text][Discuss] | 2023-06-17
Effective on 9/1/23 |
| TX | HB4990 | Pass | Relating to the Texas Pharmaceutical Initiative and a governing board and advisory council for the initiative.
[Detail][Text][Discuss] | 2023-06-13
Effective immediately |
| TX | HB25 | Pass | Relating to wholesale importation of prescription drugs in this state; authorizing a fee.
[Detail][Text][Discuss] | 2023-06-12
Effective on 9/1/23 |
| TX | HB1794 | Pass | Relating to funding for The University of Texas at Tyler's school of pharmacy.
[Detail][Text][Discuss] | 2023-06-10
Effective immediately |
| TX | SB2173 | Pass | Relating to a pilot program for the safe disposal of prescription drugs, including controlled substance prescription drugs.
[Detail][Text][Discuss] | 2023-05-29
Effective on 9/1/23 |
| TX | HB1105 | Engross
Sine Die | Relating to preventative health care and public health, including prohibited immunization and face-covering requirements, private business or school closures, and the ordering and administration of immunizations by a pharmacist.
[Detail][Text][Discuss] | 2023-05-26
House appoints conferees-reported |
| TX | SB695 | Engross
Sine Die | Relating to funding for The University of Texas at Tyler's school of pharmacy.
[Detail][Text][Discuss] | 2023-05-23
Placed on General State Calendar |
| TX | HB1190 | Engross
Sine Die | Relating to the prescribing and ordering of Schedule II controlled substances by certain advanced practice registered nurses and physician assistants.
[Detail][Text][Discuss] | 2023-05-11
To Senate Health & Human Services Committee |
| TX | SB2212 | Engross
Sine Die | Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.
[Detail][Text][Discuss] | 2023-05-06
To House Public Health Committee |
| TX | HB2088 | Engross
Sine Die | Relating to the regulation of the practice of pharmacy.
[Detail][Text][Discuss] | 2023-05-05
To Senate Health & Human Services Committee |
| TX | SB301 | Engross
Sine Die | Relating to prescribing, administering, or dispensing ivermectin or hydroxychloroquine sulfate.
[Detail][Text][Discuss] | 2023-04-28
To House Public Health Committee |
| TX | HB1293 | Intro
Sine Die | Relating to the reimbursement of prescription drugs under Medicaid and the child health plan program.
[Detail][Text][Discuss] | 2023-04-25
To House Human Services Committee |
| TX | SB1138 | Intro
Sine Die | Relating to health benefit plan coverage of clinician-administered drugs.
[Detail][Text][Discuss] | 2023-04-19
To Senate Health & Human Services Committee |
| TX | SB2402 | Intro
Sine Die | Relating to the creation, management, and administration of the Texas Pharmaceutical Initiative.
[Detail][Text][Discuss] | 2023-04-19
To Senate Health & Human Services Committee |
| TX | HB594 | Intro
Sine Die | Relating to the provision of telepharmacy services.
[Detail][Text][Discuss] | 2023-04-17
To House Public Health Committee |
| TX | HB1373 | Intro
Sine Die | Relating to a pilot program for the safe disposal of controlled substance prescription drugs.
[Detail][Text][Discuss] | 2023-04-17
To House Public Health Committee |
| TX | HB2079 | Intro
Sine Die | Relating to the authority of pharmacists to order and furnish certain prescription drugs.
[Detail][Text][Discuss] | 2023-04-17
To House Public Health Committee |
| TX | HB5129 | Intro
Sine Die | Relating to the delegation to a pharmacy technician of a pharmacist's authority to administer an immunization or vaccine.
[Detail][Text][Discuss] | 2023-03-24
To House Public Health Committee |
| TX | HB5298 | Intro
Sine Die | Relating to a pilot program under which lockable, tamper-evident containers are used by participating pharmacies when dispensing schedule II controlled substances.
[Detail][Text][Discuss] | 2023-03-24
To House Public Health Committee |
| TX | HB5249 | Intro
Sine Die | Relating to prohibiting a public entity from providing financial assistance for abortion or abortion-related services; providing civil penalties.
[Detail][Text][Discuss] | 2023-03-24
To House State Affairs Committee |
| TX | SB2378 | Intro
Sine Die | Relating to prohibiting a public entity from providing financial assistance for abortion or abortion-related services; providing civil penalties.
[Detail][Text][Discuss] | 2023-03-23
To Senate State Affairs Committee |
| TX | HB4581 | Intro
Sine Die | Relating to the regulation of the practice of pharmacy.
[Detail][Text][Discuss] | 2023-03-22
To House Public Health Committee |
| TX | HB4341 | Intro
Sine Die | Relating to promoting, prescribing, administering, or dispensing prescription drugs for off-label use.
[Detail][Text][Discuss] | 2023-03-21
To House Public Health Committee |
| TX | HB3774 | Intro
Sine Die | Relating to civil and criminal liability for pharmacists and pharmacies that dispense misoprostol.
[Detail][Text][Discuss] | 2023-03-20
To House Public Health Committee |
| TX | HB3152 | Intro
Sine Die | Relating to the identification of the country of manufacture on the label for a prescription drug or biological product.
[Detail][Text][Discuss] | 2023-03-15
To House Public Health Committee |
| TX | HB3082 | Intro
Sine Die | Relating to a pharmacy, pharmacist, or pharmacy technician decision to not dispense or sell a drug according to religious belief or moral conviction.
[Detail][Text][Discuss] | 2023-03-14
To House Public Health Committee |
| TX | SB749 | Intro
Sine Die | Relating to the administration of a medication and the ordering and administration of an immunization or vaccination by a pharmacist.
[Detail][Text][Discuss] | 2023-03-08
To Senate Health & Human Services Committee |
| TX | HB972 | Intro
Sine Die | Relating to warning labels for opioid prescription drugs.
[Detail][Text][Discuss] | 2023-03-02
To House Public Health Committee |
| TX | HB1050 | Intro
Sine Die | Relating to the authority of pharmacists to dispense self-administered hormonal contraceptives.
[Detail][Text][Discuss] | 2023-03-02
To House Public Health Committee |
| TX | HB815 | Intro
Sine Die | Relating to distinctive packaging for opioid prescription drugs.
[Detail][Text][Discuss] | 2023-03-01
To House Public Health Committee |
| TX | HB816 | Intro
Sine Die | Relating to warning labels for opioid prescription drugs.
[Detail][Text][Discuss] | 2023-03-01
To House Public Health Committee |
| TX | HB814 | Intro
Sine Die | Relating to an acknowledgment on receipt of an opioid prescription drug.
[Detail][Text][Discuss] | 2023-03-01
To House Public Health Committee |
| TX | HB235 | Intro
Sine Die | Relating to the authority of pharmacists to furnish certain medications.
[Detail][Text][Discuss] | 2023-02-23
To House Public Health Committee |
| TX | SB555 | Intro
Sine Die | Relating to the regulation of certain pharmacies.
[Detail][Text][Discuss] | 2023-02-17
To Senate Business & Commerce Committee |
| TX | SB160 | Intro
Sine Die | Relating to the furnishing by pharmacists and dispensing by physicians of certain medications.
[Detail][Text][Discuss] | 2023-02-15
To Senate Health & Human Services Committee |
| TX | SB300 | Intro
Sine Die | Relating to a pharmacist's authority to refuse to dispense a drug.
[Detail][Text][Discuss] | 2023-02-15
To Senate State Affairs Committee |
